Search

everythinglearnresearchcommunity

for

Search:↓

Australia needs better dermatological guidelines for gender-diverse patients.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Women may need different blood pressure guidelines than men for heart disease prevention.

Finasteride may lower cholesterol and slow heart disease progression.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Hair restoration helps transgender patients achieve desired gender appearances.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Feminizing hormone therapy increases kidney filtration rate.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.